BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38502313)

  • 1. Synchronous versus metachronous spinal metastasis: a comparative study of survival outcomes following neurosurgical treatment.
    Banat M; Potthoff AL; Hamed M; Borger V; Scorzin JE; Lampmann T; Asoglu H; Khalafov L; Schmeel FC; Paech D; Radbruch A; Nitsch L; Weller J; Herrlinger U; Toma M; Gielen GH; Vatter H; Schneider M
    J Cancer Res Clin Oncol; 2024 Mar; 150(3):136. PubMed ID: 38502313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival after resection of brain metastasis: impact of synchronous versus metachronous metastatic disease.
    Potthoff AL; Heimann M; Lehmann F; Ilic I; Paech D; Borger V; Radbruch A; Schäfer N; Schuss P; Vatter H; Herrlinger U; Schneider M
    J Neurooncol; 2023 Feb; 161(3):539-545. PubMed ID: 36695975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease.
    Heron DE; Komarnicky LT; Hyslop T; Schwartz GF; Mansfield CM
    Cancer; 2000 Jun; 88(12):2739-50. PubMed ID: 10870056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Factors for Survival of Patients With Synchronous or Metachronous Brain Metastasis of Renal Cell Carcinoma.
    Choi SY; Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
    Clin Genitourin Cancer; 2017 Dec; 15(6):717-723. PubMed ID: 28552571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Synchronous Versus Metachronous Onset of Colorectal Peritoneal Metastases on Survival Outcomes After Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Multicenter, Retrospective, Observational Study.
    Hentzen JEKR; Rovers KP; Kuipers H; van der Plas WY; Been LB; Hoogwater FJH; van Ginkel RJ; Hemmer PHJ; van Dam GM; de Hingh IHJT; Kruijff S
    Ann Surg Oncol; 2019 Jul; 26(7):2210-2221. PubMed ID: 30877495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase in the incidence of synchronous and metachronous peritoneal metastases in patients with colorectal cancer: A nationwide study.
    Lurvink RJ; Bakkers C; Rijken A; van Erning FN; Nienhuijs SW; Burger JW; Creemers GJ; Verhoef C; Lemmens VE; De Hingh IH
    Eur J Surg Oncol; 2021 May; 47(5):1026-1033. PubMed ID: 33272737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer.
    Fleckenstein J; Petroff A; Schäfers HJ; Wehler T; Schöpe J; Rübe C
    BMC Cancer; 2016 Jun; 16():348. PubMed ID: 27255302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synchronous Metastatic Clear-Cell Renal Cell Carcinoma: A Distinct Morphologic, Immunohistochemical, and Molecular Phenotype.
    Kammerer-Jacquet SF; Brunot A; Pladys A; Bouzille G; Dagher J; Medane S; Peyronnet B; Mathieu R; Verhoest G; Bensalah K; Edeline J; Laguerre B; Lespagnol A; Mosser J; Dugay F; Belaud-Rotureau MA; Rioux-Leclercq N
    Clin Genitourin Cancer; 2017 Feb; 15(1):e1-e7. PubMed ID: 27444986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The results of modern surgical therapy for multiple primary lung cancers.
    Adebonojo SA; Moritz DM; Danby CA
    Chest; 1997 Sep; 112(3):693-701. PubMed ID: 9315801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple Pulmonary Resections for Synchronous and Metachronous Lung Cancer at Two Chinese Centers.
    Kang X; Zhang C; Zhou H; Zhang J; Yan W; Zhong WZ; Chen KN
    Ann Thorac Surg; 2020 Mar; 109(3):856-863. PubMed ID: 31765616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Impact of time of occurrence of liver metastases (synchronous vs. metachronous) on early postoperative outcome and long-term survival of colorectal cancer patients].
    Bova R; Kamphues C; Neuhaus P; Puhl G
    Zentralbl Chir; 2014 Apr; 139(2):220-5. PubMed ID: 23846535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of synchronous and metachronous bilateral breast cancer.
    Kollias J; Ellis IO; Elston CW; Blamey RW
    World J Surg; 2001 Sep; 25(9):1117-24. PubMed ID: 11571945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metachronous advanced neoplasia after submucosal invasive colorectal cancer resection.
    Minamide T; Ikematsu H; Murano T; Kadota T; Shinmura K; Yoda Y; Hori K; Ito M; Yano T
    Sci Rep; 2021 Jan; 11(1):1869. PubMed ID: 33479474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synchronous and metachronous colorectal cancers: distinct disease entities or different disease courses?
    Huang CS; Yang SH; Lin CC; Lan YT; Chang SC; Wang HS; Chen WS; Lin TC; Lin JK; Jiang JK
    Hepatogastroenterology; 2015; 62(138):286-90. PubMed ID: 25916050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of synchronous and metachronous multiple primary lung cancers: systematic review and meta-analysis.
    Jiang L; He J; Shi X; Shen J; Liang W; Yang C; He J
    Lung Cancer; 2015 Mar; 87(3):303-10. PubMed ID: 25617985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and prognosis of synchronous and metachronous colon cancer metastases: a French population-based study.
    Ghiringhelli F; Hennequin A; Drouillard A; Lepage C; Faivre J; Bouvier AM
    Dig Liver Dis; 2014 Sep; 46(9):854-8. PubMed ID: 24908575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple primary lung carcinomas: prognosis and treatment.
    Rosengart TK; Martini N; Ghosn P; Burt M
    Ann Thorac Surg; 1991 Oct; 52(4):773-8; discussion 778-9. PubMed ID: 1929628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiofrequency ablation of T1 lung carcinoma: comparison of outcomes for first primary, metachronous, and synchronous lung tumors.
    Ridge CA; Silk M; Petre EN; Erinjeri JP; Alago W; Downey RJ; Sofocleous CT; Thornton RH; Solomon SB
    J Vasc Interv Radiol; 2014 Jul; 25(7):989-96. PubMed ID: 24703321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilateral Breast Cancer After Multimodality Treatment: A Report of Clinical Outcomes in an Asian Population.
    Wadasadawala T; Lewis S; Parmar V; Budrukkar A; Gupta S; Nair N; Shet T; Badwe R; Sarin R
    Clin Breast Cancer; 2018 Aug; 18(4):e727-e737. PubMed ID: 29254601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of KRAS mutation status in metachronous and synchronous metastatic colorectal adenocarcinoma.
    Rose JS; Serna DS; Martin LK; Li X; Weatherby LM; Abdel-Misih S; Zhao W; Bekaii-Saab T
    Cancer; 2012 Dec; 118(24):6243-52. PubMed ID: 22674181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.